Researchers say, “It turns out SSRIs don’t just make our brains happier; they also make our T cells happier—even while ...

Immunotherapies are undoubtedly transforming the landscape of cancer treatment worldwide. By harnessing the body's immune ...

Selective serotonin reuptake inhibitors (SSRIs) significantly increased the ability of T cells to suppress tumor growth in various cancer types. | Drug Discovery And Development ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

SSRIs boosted the ability of T cells to kill cancer cells and suppressed tumor growth in both mouse and human tumor models.

From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...

Media ReleaseCOPENHAGEN, Denmark; May 27, 2025Genmab A/S (Nasdaq: GMAB) announced today that its Chief Financial Officer Anthony Pagano will participate in a fireside chat at the 46th Goldman Sachs ...

During a live event, Samuel M. Rubinstein, MD, discussed the efficacy and safety outcomes from the KarMMa-3 trial.

A common class of antidepressant medications might be even more useful than we thought. Research out today suggests that ...

The antibody PLT012 targets the fat transporter CD36 to restore immune responses in tumors, offering a new and promising ...

A new study is the first phase 3 to show meaningful improvement in both progression-free and overall survival with first-line ...